Cargando…

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso

BACKGROUND: Widespread artemisinin resistance in Africa could be catastrophic when drawing parallels with the failure of chloroquine in the 1970s and 1980s. This article explores the role of anti-malarial market characteristics in the emergence and spread of arteminisin resistance in African countri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guissou, Rosemonde M., Amaratunga, Chanaki, de Haan, Freek, Tou, Fatoumata, Cheah, Phaik Yeong, Yerbanga, R. Serge, Moors, Ellen H. M., Dhorda, Mehul, Tindana, Paulina, Boon, Wouter P. C., Dondorp, Arjen M., Ouédraogo, Jean Bosco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498571/ https://www.ncbi.nlm.nih.gov/pubmed/37705004 http://dx.doi.org/10.1186/s12936-023-04705-0

Ejemplares similares

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
por: Tindana, Paulina, et al.
Publicado: (2022)

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
por: de Haan, Freek, et al.
Publicado: (2021)

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
por: Tindana, Paulina, et al.
Publicado: (2021)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021)

Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination
por: Dhorda, Mehul, et al.
Publicado: (2021)

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria
por: Mokuolu, Olugbenga Ayodeji, et al.
Publicado: (2023)

Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study
por: de Haan, Freek, et al.
Publicado: (2022)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
por: Cao, Van Anh Thi, et al.
Publicado: (2023)

Cost of introducing and delivering malaria vaccine (RTS, S/AS01(E)) in areas of seasonal malaria transmission, Mali and Burkina Faso
por: Diawara, Halimatou, et al.
Publicado: (2023)

Pilot study on agricultural pesticide poisoning in Burkina Faso
por: Toe, Adama M., et al.
Publicado: (2013)

Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
por: de Haan, Freek, et al.
Publicado: (2023)

Substandard anti-malarial drugs in Burkina Faso
por: Tipke, Maike, et al.
Publicado: (2008)

Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria
por: de Wit, Mariken, et al.
Publicado: (2021)

Biological alterations and self-reported symptoms among insecticides-exposed workers in Burkina Faso
por: Toe, Adama M., et al.
Publicado: (2012)

Is there evidence of anti-malarial multidrug resistance in Burkina Faso?
por: Rasmussen, Charlotte, et al.
Publicado: (2021)

Long-term effects of increased adoption of artemisinin combination therapies in Burkina Faso
por: Zupko, Robert J., et al.
Publicado: (2022)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia
por: Mukherjee, Angana, et al.
Publicado: (2017)

Preparing an Insectary in Burkina Faso to Support Research in Genetic Technologies for Malaria Control
por: Guissou, Charles, et al.
Publicado: (2022)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021)

The key actors maintaining elders in functional autonomy in Bobo-Dioulasso (Burkina Faso)
por: Berthé, Abdramane, et al.
Publicado: (2014)

Effect of zinc added to a daily small-quantity lipid-based nutrient supplement on diarrhoea, malaria, fever and respiratory infections in young children in rural Burkina Faso: a cluster-randomised trial
por: Somé, Jérôme W, et al.
Publicado: (2015)

Countrywide Survey of Plants Used for Liver Disease Management by Traditional Healers in Burkina Faso
por: Tibiri, André, et al.
Publicado: (2020)

Spatial modelling of malaria prevalence associated with geographical factors in Houet province of Burkina Faso, West Africa
por: Millogo, Abdoul Azize, et al.
Publicado: (2022)

Arsenic levels in tube-wells water, food, residents’ urine and the prevalence of skin lesions in Yatenga province, Burkina Faso
por: Somé, Issa T., et al.
Publicado: (2012)

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
por: Tinto, Halidou, et al.
Publicado: (2014)

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
por: Tun, Kyaw Myo, et al.
Publicado: (2018)

Trajet de soins des personnes âgées à Bobo-Dioulasso, au Burkina Faso: une enquête transversale
por: Hien, Hervé, et al.
Publicado: (2015)

Prevalence of symptoms of sleep apnoea syndrome in Burkina Faso
por: Ouédraogo, G, et al.
Publicado: (2019)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Cytotoxicity of Particulate Matter PM(10) Samples from Ouagadougou, Burkina Faso
por: Guissou, Joelle Nicole, et al.
Publicado: (2022)

Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives
por: O’Flaherty, Katherine, et al.
Publicado: (2019)

Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2023)

Sahel terrorist crisis and development priorities: case of financial allocations for the control of non-communicable diseases in Burkina Faso
por: Ouedraogo, Moussa, et al.
Publicado: (2023)

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria
por: Intharabut, Benjamas, et al.
Publicado: (2019)

Extensively Drug-Resistant Tuberculosis, Burkina Faso
por: Saleri, Nuccia, et al.
Publicado: (2010)

Mycobacterium sherrisii Pulmonary Disease, Burkina Faso
por: Borroni, Emanuele, et al.
Publicado: (2015)

First Investigative Study of Azole-Resistant Aspergillus fumigatus in the Environment in Burkina Faso
por: Yerbanga, Isidore W., et al.
Publicado: (2021)

Could Covid-19 Worsen Food Insecurity in Burkina Faso?
por: Zidouemba, Patrice Rélouendé, et al.
Publicado: (2020)

Prevalence of obstructive sleep apnoea in sleep consultations in Burkina Faso: Implications for monitoring
por: Ouédraogo, A R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ef9bt1pvoblduv6hv812vk6jfu